What We're Reading: Page 40
Industry reads hand-picked by our editors
Jul 29, 2024
Jul 26, 2024
Jul 25, 2024
Jul 24, 2024
-
The New York Times
A Disease That Makes Children Age Rapidly Gets Closer to a Cure
-
BioSpace
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
-
New England Journal of Medicine
The Real Purpose of PrEP — Effectiveness, Not Efficacy
Jul 23, 2024
-
Reuters
Drug giants eye China for deals despite growing Sino-US tensions
-
Financial Times
Novartis warns prostate cancer drug price will remain high
-
FirstWord Pharma
With IPO on ice, radiopharm developer Telix to raise nearly $400M in bond sale
-
KFF Health News
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs
Jul 22, 2024
-
Axios
Biden’s fragile legacy on health care
-
C&EN
Lead seeks to lead in radiopharma
-
MIT Technology Review
Why we need safeguards against genetic discrimination
Previous
